disease contraception , oral contraceptive use , postmenopausal estrogen replacement , Gallium-67, thyroid scan using, Gallium nitrate effects endocrine function values, hypecalcemia, hypocalcemia caused by, Gallstones cholesterol, with somatostatin analog therapy, diabetes, obesity , hyperparathyroidism risk factors , diabetes, Gamete(s). Embryo; Zygote meiosis, Camete intrafallopian transfer, Gamma-aminobutyric acid (GABA), appetite regulation, chemistry corticotrophin-releasing hormone secretion, hypothalamic activity, as prelatic-inhibiting factor, somatostatin release, structure , thyrotropin-relasing hormone release, Gammma-aminobutyric acid (GABA) receptor(s) GABAB, glucocorticoids , Gamma cell(s). G cell(s), pancreatic Gamma knife, definition , Ganciclovir effects endocrine , Ganciclovir effects endocrine function values, therapy with CMV infection organ transplant, HIV infected (AIDS) patients endocrinologic side effects , indications , Ganda, Om P., Gangliocytoma(s) intrasellar, sellar region, nomenclature , Ganlioglioma(s), hypothalamic, Ganglion cells, precursors fo, Ganglioneuroblastoma(s), catecholamine production by, pathology , ganglieuroma(s), catecholamine production by, epidemiology , MEN2b, pathology , Ganglionic synapse, Ganglioside GM2-1, antibodies , Gangliosidosis,. Tay-sachs disease clinical features , GM1, atypical variants , genetics , ocular manifestationsof, type 1, ocular manifestations , type 2, ocular manifestations fo, GM2 clinical features , juvenile, ocular effects , ocular manifestation , type 1. Tay-Sachs disese type 2. Sandhoff disease type3, ocular manifestations , variants , clinical features , infantile GM1, Clinicla course , clinical features , ocular effects , juvenile generalized. Gangliosidois, GM1, type 2 juvenile GM2, ocular effects , late infantile GM1, clinical course , clinical features , ocular involvement , Gangrene foot/limb, diatetes. Dibetic foot gallbladder, diabetes, Garnirelix acetate (Antagon) action , adverse effects side effects , dosage administration , indication , preparations , GAP. GnRH-associated peptide Gap junctions granulosa cells, oocyte growth, mymetrial parturition, preimplantation embryo, Gardner syndrome clinical features , endocrine lesions , thyroid cancer , Gargoylism. Hurler syndrome Garibaldi, Luigi, Garlic, antiatherogenic effects , Garrod, Archibald, Gas chromatography/mass spectrometry, Gastrectomy partial, osteomalcia after subtotal, osteoporosis after, Gastric acid secretion adrenal function , calcitonin , central regulation , Cushing syndrome, excess, peptic ulcer disease, histamine , hypoprathyroidism , PGE , somatostatin , tyroid dysfunction , Zollinger-Ellison syndrome, Gastric cancer acantosis nigricans with, hyperadrenocorticism (Cushin disease, Cushing syndrome), hypercalcemia with, Gastric emptying. Gastrointestinal motility delayed anorexia nervosa, diabetes, pregnancy, Gastric inhibitory polypeptide (GIP). Glucose-dependent insulingtropic polypeptide Gastric motility, hypothalamus , Gastric mucosa hermorrhagic lesions , hypothalamus , hypertrophy , Gastric pH, hypothalamus , Gastrin, actions , calcitionin secretion, diffuse neuroendocrien system, discover , effects endocrine function values, gene , oncofetal expression , tissue distribution , human chorionic, pancreatic islet cells, pathophysiology , plssma/serum level Cushin syndrome, elevated, causes , erythropoietin therapy , renal disease, precursor , production , stimulatory dynamic tests , reference values , secretion , calcitonin , calcium-induced, by gastrointestinal tumors, somatostatin , Zollinger-Ellison syndrome, synthesis , cell-specific processing , transhepatic venous sampling, gastrinoma, trophic effects , tumors producing. Gastrinoma(s) MEN1, Gastrin-34, structure , Gastrinoma(s), age at presentation , characteristics , chemotherapy , diagnosis , secretin provocative test , differentiation from insulinomas, duodenal, gastric acid secretion with, incidental, gastric acid secretion with, incidence , localization , radiologic, malignant, medical therapy , MEN1, metastases , detection , natural history , postoperative follow-up , genital distribution , somatostatin receptors , surgery , survival rate with, treatment , tumor marker , Gastrinoma triangle, Gastrin-releasing peptide (GRP), Bombesin; Bombesin-like peptides actions , central nervous system effect , genitourinary system, precursor , structure , structure , Gastroenterpancreatic neuroendocrine, tumor(s), emblization , complications , contraindications , method , functioning versus nonfunctioning, MEN1, metastases chemoembolization , hepatic, mRNA , somatostatin receptors, somatostatin analogs , somatostatin receptors , tumor markers , Gastroesophageal reflux disease (GERD), hyperparathyroidism, Gastintestinal bleeding sclerotherapy , vasopressin therapy , Gastrointestinal disease, hypogonadotropic hypogonadism , octreotide , osteomalacia ,osteoporosis, , Gastrointestinal motility, anorexia nervosa, with medullary thyroid carcinoma, opioids , thyroid dysfunction , Gastrointestinal peptides breast milk, satiety , Gastrointestinal system calcitonin , calcitonin , calcium absorption impaired osteomalacia with, parathyroid hormone , catecholamines , contraception , contraception , diffuse neuroendocrien system , distal, hormones , as endocrine organ, endocrine tumors ,Gastrinoma(s); Glucagonorma(s). Neurotensinoma; PPoma; Somatostatinoma(s) VIPoma(s) endocrinopathy , endogenous opioids , epithelia cell diffuse neuroendocrine system, function , hormones , hormone-secreting tumors , hormones , hypothalamus , inherited disorders amino-acid metabolism, innervation , extrinsic system , intrinsic system , paracrine regulation , phosphate homeostasis, somatostatin thyroid disorders , Gastrointestinal tract. Gastrointestinal system, Gastroparesis, diabetic, treatment , Gastropathy, diabetic, Gastroplasty, vertical-banded, weight loss, Gastrostomy tube, enteral feeding , GATA3gene, Gaucher cell, Gaucher disease, clinical features , ocular manifestations , treatment , type 1 clinical course , clinical features , disease associations, genetics , type 2 clinical features , genetics , Gaussian statistics, limitations , GAWK, as marker neuroendocrine tumors, Gaza, downward, paralysis , causes , G-banding, G cell(s) gastric (antral), diffuse neuroendocrien system, gastrin synthesis , intestinal, diffuse neuroendocrine system, pancreatic, diffuse neuroendcrine system, gastrin synthesis , intestinal, diffuse neuroendocrine system, pancreatic, diffuse neuroendcrine system, GCI. Glycoprotein crystal growth-inhibitor (GCI) protein GCMB gene, G-CSF. Granulocyte colony-stimulating factor GDF-9, folliculogenesis, GDM. Gestational diabetes GDP. Guanosine diphosphate Gelastic seizures, Gelatinase(s), implantation Gel electrophoresis, Gemb gene, Gemfibrozil, adverse effects side effects , combination drug therapy with fish oil, with HMG-CoA inhibitors, with lovastatin, with niacin, contraindications , pregnancy, dosage administration , drug interactions with, effects endocrine function values, indications , lipid-lowering effects , therapy with diabetic dyslipidemia, HIV-infected(AIDS) patients, indications , lowering triglyceride levels Gencale 600. Calcium carbonate Gender assignment. Ambiguous genitalia, Gender identification, genital steroids , Gene(s),. Oncogene(s); Proto-oncogene(s) specific gene alternative processing , pathologic physiologic effects , amplification , by polymerase chain reaction, candidate, type 1 diabetes. type 2 diabetes, chimeric, dexamethasone-suppressible hyperaldosteronism, cloning , duplication , expression , conditional (developmental) interruption , fetal development, profiling , DNA arrays , quantitative assessment , floxed, homologous, evolution , imprinting , incompletely penetrant, introduction , into mammalian cells, isolation , mapping , chromosomes, strategies , mutations , pathologic physiologic effects , nonpenetrant, penetrance, polypeptide hormone, informational flow from, steroid-regulated, structure , transcription, activation, activation, assays , CALC-I gene, cAMP , collagen, Gene(s) (continued) definition , derepression, glucocorticoids , hormonal regulation human chrionic gonadotropin subunit, trans-acting factors cis-acting elements , osteocalcin, parathyroid hormone-related protein, relative rates , repression, transcription rate, basal, regulated, Gene ablation (knock-outs), Knock-out mice libraries, Gene conversion, Gene gun technique, DNA-based vaccination, Gene knock-out libraries, General adaptation syndrome, Gene therapy, ex vivo, hypertension, vivo, Lesch-Nyhansyndrome, problems with, replacement therapy with replacement therapy with, severe combined immunodeficiency, vectors , Genetic association, definition , genetic code, Genetic counseling, lysosomal storage disease, osteogenesis imperfecta, Genetic heterogeneity, allele, locus, Genetic linkage. Linkage analysis definition , genetic linkage map(s), Genetic obesity, Genetics. specific disorder endocrinology, genetic genital, determination , genetic testing laboratories , registries MEN1, Gene transfer protect islet transplants, vectors , Genital ambiguity. ambiguous genitalia Genital bleeding. Menstrual bleeding; Uterine bleeding; Vaginal bleeding Abnormal, evaluation , management , management , postmenopausal years, prepubertal, reproductive years, contraception , Genitalia ambiguous, age at onset , clinical evaluation amenorrhea, congenital adrenal hyperplasia, with CYP19 (aromatase) gene defects, 17 Alpha-hydroxylase/17,20-lyase deficiency, infant with clinical approach evaluation , with multiple malformation patterns, phenotypic expression , physical findings , surgical management , 46,XX genotype , development , assessment , differentiation , errors , embryology , female androgen , atresia, dysmenrrhea, atrophy hypopituitarism , menopause , internal, amenorrhea ad, tumors , prepubertal genital bleeding, male embryology , response autonomic nerve impulses, Genitla tract infection, male-factor infertility , Genital tubercle, Genitopalatocardiac syndrome, Genitourinary system blood flow , local nonadrenergic noncholinergic control , diffuse neuroendocrine system, as endocrine organ, pathophysiologic significance , local hormones , functions , peptide hormones , smooth muscle , local nonadrenergic non-cholinergic control , thyroid disorders , Genomic DNA cloning , ends , rapid amplification , Genomic imprinting, definition, Genomic libraries, gene isolation, Genotropin. Somatropin Gentamicin. Somatropin Gentamicin. Aminoglycosides effects endocrine function values, Geref. Sermorelin acetate Geriatric endocrinology. Aging; Elderly assessment , impaired homestasis , laboratory homeostasis , laboratory evaluation , difficulties with, nonspecific atypical presentation , principles , treatment , Germ cell(s) aplasia, germ cell failure , testicular, disorders affecting, hypoplasia, testicular, migration, defective, stem cell replication, primordial, migration , stem cell replication, Sertoli cells, Germ-cell-genital-cord tumor nongonadoblastoma type, ovary, Germ-cell tumor(s). Choriocarcinoma; Embryonal tumor(s); Germinoma; Teratoma; Testicular cancer; Testis/testes, carcinoma situ delayed puberty, extragonadal, carcinoma situ , intracranial chemotherapy , radiation therapy , mixed, ovary, primary ovarian carcinoids, rete testis, screening , sellar region, imaging , testicular. Testicular tumors, germ cell yolk sac (endodermal sinus), Germinal cell aplasia, testicular, Germinal center, definition , Germinal vesicle, Germinoma diabetes insipidus caused by, hypothalamic chemotherapy , imaging , radiation therapy , sellar region, imaging , Gestational diabetes, acromegaly, de morsier syndrome, diagnosis , dietary therapy , exercise , home blood glucose monitoring , incidence , insulin therapy , Insulin therapy labor delivery, neonatal care with, obese women, obesith, ora contraceptives , pathophysiology , postpartum course , postpartum management , prevalence , risk type 2 diabetes, screening , treatment , Gextational disease, Gestational pemphigoid, Gestational trophoblastic disease, Choriocarcinoma; Hydatidi-from mole; Placental site lesions; Placental site trophoblastic tumor differential diagnosis , human chorionic gonadotropin , hyperthyroidism , oral contraceptive , ovarian involvement , paraneoplastic syndromes with, World Health Organization (WHO) classification , Gestodene, thromboembolic disease, Gestrinone, endometriosis, GFR. Glomerular filtration rate G-free cassette, GH. Growth hormone (GH), insensitivity Ghrelin, GH secretion, GHRH. Growth hormone-releasing hormone GHRPs. Growth hormone-releasing peptide(s) GI198745,  dysfunction, Giant cell arteritis, hyperthyroidism, Gaiant-cell granuloma, pituitary, Giant-cell tumor(s), Paget disease bone, Giardiasis, hypothyroidism with, Gibbons, Gary W., Giemsa banding (G-banding), GIF. Gamete intrafallopian transfer Gigantism cerebaral hypothalamic-pituitary axis , infancy childhood, pathophysiology , pituitary, causes , clinical presentation , denta/orofacial abnormalities , treatment , Gilbert-Dreyfus syndrome, Gill, John R., Jr.,Gingivitis hyperplastic drug-induced, endocrine/metabolic causes, , oral contraceptives , pregnancy, Ginsberg, Henry N., GIP. Glucose-dependent insulinotropic polypeptide, Girls growth charts , pubertal growth , Gitelman syndrome, GLA. Y-Carboxyglutamic acid Gland(s), ductless, hormone secretion by, exocrine definition , multicellular, unicellular, hormone secretion by, Galans pennis, development , Gla protein. Bone Gla Protein Glargine,. Bone Gla protein Glargine,. Insulin, Ultralente Glaser, Joel S., Glasgow Coma Score, correlation with serum cortisol levels, Glass, Allan R., Glaucoma, causes , congenital, conditions simulating, corticosteroid-induced, diabetes, cataract extraction , with proliferative retinopathy, drug therapy , glucocorticoid, interactions , elderly, diabetes , low-tension, empty sella syndrome, metabolic disease , neovascular extraction , proliferative diabetic retinopathy , open-angle diabetes, familial, natriuretic peptides , hyperreponsiveness glucocorticoids , pregnancy , with shallow anterior chamber, cystinosis, treatment , neutral endopeptidase inhibitors , uveitis, GLC. Chromatography, gas-liquid Gleason score, prostate cancer, Glia activating factor (GAF), biologic response , Glia maturation factor (GMF), biologic response , Glibenclamide. Glyburide Glicentin, pancreatic islet cells, secretion , synthesis , Glicentin-related pancreatic polypeptide (GRPP), synthesis , Gliclazide, dialysis patient, structure , Glimepiride (Amaryl), actions , adverse effects side effects , dialysis patient, dosage administration , effects endocrine function values, indication preparations , Glioblastoma, hypothalamic, malignant, Glioma(s) adults, chiasmal, chemotherapy , diabetes insipidus caused by, differential diagnosis , hypothalamic, Diencephalic syndrome chemotherapy , imaging , radiation therapy , surgery , imaging , indolent, childhood, intraorbital, neuroradiologic biopsy , nonvision complications , optic nerve, opticochiasmatic, imaging , opic pathway, gonadotropin-dependent precocious puberty , pituitary, prognosis , radiation- induced, radiation therapy , dosage administration , radiosurgery , somatostatin receptors , treatment , vision complications , Glipizide (Glucotrol),. Sulfonylurea (s) actions , adverse effects side effects , dosage administration , effects endocrine function values, hepatotoxicity , indications , pharmacology , preparations , structure , therapy with diabetes, elderly, dialysis patient, Globe disorders , endocrine/metabolic causes , soft, diabetic coma, Globoid cell leukodystrophy,ocular manifestations , Globozoospermia, Glomerular filtration rate (GFR) acromegaly, adrenocortical insufficiency, angiotensin II , decreased, diabetic nephropathy, hypercalcemia, hyperthyroidism, hypothyroidism, natriuretic peptide , nonrenal hormones , primary hyperparathyroidism, prostaglandins , reduced, hypermagnesemia, regulation , negative , negative feedback , Glomerulonephritis autoimmune, nephritic syndrome, IL-8 , IL-10 , kallikrein-kinin system , Glomerulosclerosis acutemesangial proliferative, TGF-Beta , diabetic, basement membrane thickening , clinical course , diffuse nodular lesions , early renal function changes , late renal function changes , pathogenesis , acquired (metabolic/hemodynamic) theory , genetic theory , Glomerulus/glomeruli, anatomy , Glomus cell(s), type 1, Glossitis with gluccagonoma, median rhomboid, diabetes, glossodynia diabetes, endocrine/metabolic causes , postmenopausal, GLP. Glucagon-like peptide glucagons, action , acute-phase response, adverse effects side effects , appetile regulation, calcitonin secretion, cardvascular effects , central nervous system effects , critical illness, acute versus chronic phase, deficiency , diabetes, diagnosis pheochromocytoma, diffuse neuroendocrine system, dosage administration , effects endocrine function values, exercise , feeding behavior, fetal, fructose-2-6-biphosphate , gastrointestinal effects ingluconeogenesis, glucose level, hepatic glycogenolysis, hepatic protein synthesis, hepatobiliary effects , hypoglycemia, indications , insulin action, metabolic effects , pancreatic, secretion , calcitonin , paracrine effects , pancreatic islets, plasma/ serum level . Hyperglucagomia, erythropoietin therapy , factors affecting, fasting, liver transplant recipient, inrenal failure, precursor , production , productioj protein metabolism , reference values , release, factors affecting, renal metabolism , renal responses , satiety , secretion , cytokines , eicosanoids , glucocorticoids , glucose , modulators , neural factors affecting, pulsatile, regulation , response hemorrhage, somatostatin , somatostatin, starvation , structure , subcutaneous administration , pregnant diabetic, synthesis , cell-specific processing , therapy with, critical illness, thymus, tumors producing. Glucagonoma(s) urinary tract effects , Glucagon family peptides (GFP), diffuse neuroendocrine system, Glucagon-like peptide GLP-1, action , appetite, central nervous system effects , secretion, structure , GLP-2 action , epithelial cell proliferation gut, secretion , structure , therapeutic potential type 2 diabetes, type 2 diabetes treatment, Glucagon-like peptide receptors(s), GLP-1, signaling pathways, Glugaconoma(s) age at presentation , characteristics , clinical features , cutaneous manifestations , diagnosis , glucose intolerance with, incidence localization , MEN 1, metastases , treatment , treatment , palliative care , genitaldistribution , solitary, localized, treatment , somatostatin receptors , treatment , Glucagon receptor(s) renal, signaling pathways, Glucagon receptor antagonist(s), Glucagon-stimulated C peptide test drug effects , expected response , intraindividual variation , method , physiologic factors affecting, special considerations/interpretation , substance measured , Glucocerebrosidase deficiency, ocular effects , Glucocorticoid(s), absorption , ACTH secretion, adiposity, adjuvant therapy with, adverse effect side , prevention , antepartum administration , anti-inflammatory effects , antistress effects , appetite regulation, arachidonic acid derivatives, atrial natriuretic peptide synthesis, bioavailability , biological effects , diversity , biotransoformation , skiin, blood cells, blood pressure, bone, breast milk, calcium, carbohydrate metabolism, cardiovascular effects , catabolic effects , catecholamine actions, central nervous system effects , circulatory effects kof, connective tissue, critical illness, deficiency , aminoglutethimide-induced, clinical characteristics , diabetes insipidus with,familial isolated metabolic effects treatment , vasopressin levels , depression, dermal effects , development, distribution circulation, dosage administration , drug interactions with, duration action , effects endocrine function values, eosinopenia excess children, diabetes secondary , metabolic effects , psychiatric manifestations , serum osteocalcin levels , exercise , exogenous adrenal insufficiency caused by, anti-inflammatory effects , effect , elderly, immunosuppressive effects , responsiveness , variations , vitamin D synthesis, withdrawal from, risks , feedback sensitivity , aging , fetal, fetal lung maturation, food intake, glucocoticoid potency , GnRH secretion, ad gonadal function, growth, half-life , hCG synthesis, hypercalcemia, immunologic effects , indications , insulin actin, intermediate-acting, ischemic necrosis caused by, leptin resistance, leptin secretion, lipid metabolism, long-acting, mechanism action , rheumatoid arthritis, metabolic effects , metabolism hepatic HIV-associated fat redistribution, renal, skiin, microvasculature, mineralocorticoid potency , m RNA degradation, ocular effects , osteoporosis caused by, pathogenesis , prevention , parturition, pahrmacodynamics , plasma lipid levels, plasma lipoproteins, plasma transport proteins , penumocystis carinii pneumonia caused by, prevention , POMC transcription, preparations , proapoptotic effects , tumor cells, prostaglandin production fetal membranes, protein metabolism, renal effects , resistance , , hypertension caused by, primary, septic shock, secretion , critical illness, non-ACTH-mediated regulation , cytokines , feedback regulation IL-6 , stress , thymus , short-acting, somatostatin relase, starvation, stress, structure , suppression , cervical factor infertility treatment, surfactant system, synthesis , testicular failure, T heper cells, therapy with, acute adrenal insufficiency caused by, acute lung injury, acute lung injury, acute spinal cord injury, adrenal insufficiency, children, age , alternate-day, conversion from continuous therapy definition , efficacy , failure HPA responsivensess, indication , manifestations Cushing syndrome, rationale , risks , use , anti-inflammatory, dosage , atypical Crohn disease, bone kloss prevention, bone pain, progressive diaphyseal dysplasia, breast cancer, cessation , clinical management , congenital adrenal hyperplasia, considerations before initiation , corticotrophin therapy, comparison , critical illness, dosage administration , rationale , supraphysiologic doses ,  Cushin syndrome, daily single-dose, discontinuation , dosage administration , drug interactions with, duration , endocrnologic side effects , indications , HPA suppression caused by, hypercalcemia malignancy, hyperthyroidism , immunosuppressive, dosage , intercurrent illness, labor delivery lactation, length lipid levels, lipoprotein metabolism, liver disease , nephritic syndrome , pediatric meningitis, pereoperative, Pneumocystis carinii pneumonia, , pregnancy, research needed , responsiveness , variations , septic shock, Aheehan syndrome, systemic, selection preparation , topical, indications , tuberculosis, typhoid fever, VIPoma, weaning from, children, withdrawal , children, ad thyroid function, toxic effects , transcriptional effects , TSH secretion, vasopressin secretion, vitamin D thrapy, Glucocorticoid antagonist(s), ACTH hypersecretion, Glucocorticoid receptor(s), adipose tissue, central, DNA, interaction , GR-Beta, peripheral, prostaglanding metabolism, relative cortisol resistance, renal, skiin, subcellular distribution ad transcription factors interaction , type I, type II, Glucocorticoid regulatory elements(s). Glucocorticoid response element(s) Glucocorticoid response elements(s), atypical, rat somatostatin gene, half-sites , rat somatostatin gene, Glucocorticoid-response elements.